Is gamma-linolenic acid an effective intravesical agent for superficial bladder cancer? In vitro cytotoxicity and in vivo tolerance studies

Urological Research

Volumn 26, Issue 1, 1998, Pages 11-15

  Solomon, L Z ^a   Jennings, A M ^a   Hayes, M C ^a   Bass, P S ^a   Birch, B R ^a   Cooper, A J ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cytotoxicity; Gamma linolenic acid; Intravesical therapy; Superficial bladder cancer

Indexed keywords

GAMMA LINOLENIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; BLADDER MUCOSA; CYTOTOXICITY; CYTOTOXICITY TEST; DRUG EFFECT; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUPERFICIAL CANCER;

ADMINISTRATION, INTRAVESICAL; ANIMALS; CELL SURVIVAL; FEMALE; GAMMA-LINOLENIC ACID; HUMANS; RATS; RATS, INBRED F344; TIME FACTORS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0031978410     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400050016     Document Type: Article

References (17)

1. Basha G, Yap P, Penninckx F (1996) Comparative study of classical, colorimetric and immunological staining methods for the assessment of tumor-cell viability. Tumour Biol 17:354-361
2. Begin ME, Das UN, Ells G, Horrobin DF (1985) Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 19:177-86
3. 1 on the proliferation of human osteogenic sarcoma cells in culture. Prostaglandins Leukot Med 15:15-33
4. Botha JH, Robinson KM, Leary WP (1983) Parenteral gamma-linolenic acid administration in nude mice bearing a range of human tumour xenografts. S Afr Med J 64:11-12
5. Das UN, Prasad VVSK, Raia Reddy D (1995) Local application of gamma-linolenic acid in the treatment of human gliomas. Cancer Lett 94:147-55
6. Davies CL, Duffy PM, MacRobert AJ, Loizidou MC, Cooper AJ, Taylor I (1996) Localization of anthracycline accumulation in sensitive and resistant urothelial tumor cell lines. Cancer Detect Prevent 20:625-633
7. Dippenaar N, Booyens J, Fabbri D, Katzeff IE (1982) The reversibility of cancer: evidence that malignancy in melanoma cells is gamma-linolenic acid deficiency-dependent. South Afr Med J 62:505-509
8. Freshney RI (1994) Measurement of viability and cytotoxicity. In: Culture of animal cells, 3rd edn. Wiley, New York, pp 296-298
9. 1. Med Hypoth 6:469-486
10. Leary WP, Robinson KM, Booyens J, Dippenaar N (1982) Some effects of gamma-linolenic acid on cultured human esophageal carcinoma cells. S Afr Med J 62:681
11. Masters JR, Hepburn PJ, Walker L, Highman WJ, Trejdosiewicz LK, Povey S, Parkar M, Hill BT, Riddle PR, Franks LM (1986) Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res 46:3630-3636
12. Morisaki N, Sprecher H, Milo GE, Cornwell DG (1982) Fatty acid specificity in the inhibition of cell proliferation and its relationship to lipid peroxidation and prostaglandin biosynthesis. Lipids 17:893-899
13. Nakagawa M, Emoto A, Nasu N, Hanada T, Kuwano M, Cole SPC, Nomura Y (1997) Clinical significance of multi-drug resistance associated protein and P-glycoprotein in patients with bladder cancer. J Urol 157:1260-1265
14. Sircar S, Cai F, Begin ME, Weber JM (1990) Transformation renders mdr cells more sensitive to polyunsaturated fatty acids. Anticancer Res 10:1783-1786
15. Smith B, Kennedy W, Trejdosiewicz LK, Selby PJ, Southgate J (1997) Induction of uroplakin 2 gene expression by differentiating normal human urothelial cell cultures. Br J Urol (in press)
16. Southgate J, Pitt E, Trejdosiewicz LK (1996) The effects of dietary fatty acids on the proliferation of normal human urothelial cells in vitro. Br J Cancer 74:728-734
17. Weber JM, Sircar S, Begin ME (1994) Greater sensitivity of human multidrug resistant (mdr) cancer cells to polyunsaturated fatty acids than their non-mdr counterparts. J Natl Cancer Inst 86:638-639